Hydrocortisone: Nursing Drug Guide, Adrenal Crisis Prevention & NCLEX Review
Endogenous cortisol replacement and stress-dose therapy: the bedside priority is preventing adrenal crisis from missed doses, abrupt withdrawal, or inadequate stress coverage—while recognizing that systemic hydrocortisone causes hyperglycemia, sodium retention, potassium loss, HPA suppression, and masked infection signs during immunosuppressive regimens.
Labeling warns that abrupt withdrawal after prolonged systemic corticosteroid therapy can precipitate adrenal crisis, and that dosage must be increased during unusual stress in patients on corticosteroids who are subjected to severe stress. In Addison disease, missed home hydrocortisone during critical illness or surgery can cause refractory hypotension, hypoglycemia, and cardiovascular collapse. Concurrently, immunosuppressive doses may mask fever and inflammation while glucose climbs—do not assume stability because the patient looks comfortable.
📋 Contents
⚡ Quick facts
💡 Key takeaway
At every transition of care, perform medication reconciliation for home hydrocortisone and stress-dose plans. When oral therapy is not feasible, give hydrocortisone sodium succinate IV or IM per orders. Trend glucose with bedside testing, watch for polyuria and weakness, and escalate early for hypotension or altered mental status—especially if doses were missed. Never stop chronic therapy abruptly; taper only per prescriber plan.
Most common brand names
Solu-Cortef (hydrocortisone sodium succinate) is the widely used U.S. parenteral brand for IV or IM injection when oral hydrocortisone is not feasible. Cortef tablets provide oral hydrocortisone. Generic hydrocortisone and hydrocortisone sodium succinate are available in multiple strengths—verify vial mg, tablet mg, and reconstitution volume on every pass.
Do not confuse Solu-Cortef with methylprednisolone or dexamethasone vials in crash carts; potency and duration differ even when vial labels look similar.
Why we give it — Indications
U.S. labeling lists hydrocortisone sodium succinate for anti-inflammatory and adrenocortical replacement uses when oral therapy is not feasible, including treatment of anaphylaxis, severe inflammatory states, and adrenal insufficiency. BNF lists hydrocortisone for replacement in adrenal insufficiency, physiologic stress dosing, and acute adrenal crisis. Nurses most often administer hydrocortisone for chronic primary adrenal insufficiency replacement, perioperative or critical-illness stress coverage, and acute crisis rescue alongside sepsis or trauma management.
| Use | Detail |
|---|---|
| Adrenal replacement (oral) | About 20–30 mg/day in divided doses per BNF; individualize to clinical response |
| Adrenal crisis (parenteral) | BNF: hydrocortisone 100 mg IV then 50 mg q6h or 200 mg/24h by infusion |
| Stress dosing (systemic illness/surgery) | Labeling: increase dosage during unusual stress; initial IV 100–500 mg, repeat q2–6h |
| Inflammatory / allergic emergencies | IV/IM when oral route not feasible—coordinate with resuscitation protocols for anaphylaxis |
| Rheumatoid arthritis / inflammatory disorders | Systemic corticosteroid therapy—often bridged to longer-acting agents such as prednisone per prescriber plan |
On a small screen, swipe or scroll sideways to see the full table.
How it works
Hydrocortisone is a short-acting glucocorticoid with moderate mineralocorticoid activity at physiologic replacement doses. It suppresses inflammatory mediator release, stabilizes vascular responsiveness to catecholamines, and maintains glucose homeostasis during stress. At supraphysiologic doses it causes sodium and water retention, potassium loss, hyperglycemia, lymphocyte suppression, and hypothalamic-pituitary-adrenal (HPA) axis suppression with prolonged use—meaning the patient cannot mount an endogenous cortisol response if doses are missed or stopped abruptly.
Dosing overview
Individualize to indication, route, and stress level. Labeling emphasizes that patients on corticosteroids subjected to unusual stress require increased dosage, and that high-dose IV therapy is usually not continued beyond 48 to 72 hours because prolonged administration may cause hypernatremia.
Missed dose: Not specified in the reviewed prescribing information for replacement patients; follow endocrine prescriber guidance—never omit stress coverage during acute illness. Teach patients with adrenal insufficiency to double or stress-dose per their endocrine action plan when vomiting or unable to take oral tablets.
Onset, peak, and duration
- IV hydrocortisone sodium succinate: Rapid systemic effect suitable for crisis and stress dosing when oral absorption is unreliable
- Oral hydrocortisone: Shorter duration than prednisone or dexamethasone—replacement regimens often require divided daily dosing
- HPA suppression: Develops with prolonged systemic therapy; recovery after taper may take months—carry steroid emergency identification when instructed
- Mineralocorticoid effect: Contributes to sodium retention and potassium wasting at higher or prolonged doses
Before you give it — Safety check
Pretreatment checks
- Indication: replacement, stress dose, crisis, or anti-inflammatory—match route to ability to swallow and absorb
- Latest basic metabolic panel: glucose, sodium, potassium, creatinine
- Blood pressure, heart rate, mental status, and infection cues (fever, rigors, wound changes)—corticosteroids may mask inflammation
- Review home corticosteroid history, last oral dose, and whether admission reconciliation captured hydrocortisone and stress-dose instructions
- Screen for systemic fungal infection, live vaccine plans, and pregnancy/lactation counseling when relevant
Contraindications (labeling)
- Systemic fungal infections (unless specific antifungal therapy accompanies therapy per labeling context)
- Hypersensitivity to hydrocortisone or formulation components
- Intramuscular use in idiopathic thrombocytopenic purpura (ITP)
- Intrathecal administration
Important warnings
| Issue | Effect | Nursing action |
|---|---|---|
| Immunosuppression | May mask signs of infection; new infection may occur during therapy | Do not ignore subtle sepsis cues; trend vitals, lactate, and cultures in febrile patients |
| Live vaccines | Contraindicated during immunosuppressive corticosteroid doses per labeling | Coordinate with pharmacy and prescriber before vaccine administration |
| Tuberculosis | Latent or active TB may reactivate; severe disseminated TB reported when corticosteroids used in active TB without adequate anti-TB therapy | Confirm TB screening history in long-term steroid patients |
| Diabetes / hyperglycemia | Corticosteroids raise blood glucose | Increase glucose monitoring; notify prescriber for sustained hyperglycemia |
| Abrupt withdrawal | Adrenal crisis after prolonged therapy | Never stop chronic therapy without taper; flag missed doses immediately |
On a small screen, swipe or scroll sideways to see the full table.
Administration
Oral: Give with food or milk if GI upset occurs per common practice; follow MAR timing for divided replacement doses.
- IV push (Solu-Cortef): 100 mg over 30 seconds; doses of 500 mg or more over at least 10 minutes per labeling
- Repeat dosing: Initial 100–500 mg IV may be repeated every 2 to 6 hours per labeling during acute stress
- Reconstitution: Prepare immediately before use; do not dilute or mix with other IV solutions per Solu-Cortef labeling
- IM: Acceptable when IV access is delayed—use IM injection technique and document site
Labeling states hydrocortisone sodium succinate should not be diluted or mixed with other solutions. Use high-alert medication administration double-checks for crisis doses, and confirm mg versus mL after reconstitution.
Expected therapeutic response
- Improving blood pressure and perfusion during adrenal crisis or stress dosing when hypovolemia is also corrected
- Stabilizing glucose and mental status in cortisol-deficient patients after adequate replacement
- Reduced bronchospasm or allergic inflammation when used for asthma or anaphylaxis adjunct therapy per prescriber plan
- Clinical stabilization allowing transition back to oral maintenance dosing once the patient can swallow and absorb
Red flags — Stop and act
Adrenal crisis and masked infection can overlap—hypotension may reflect both cortisol deficiency and sepsis.
- Refractory hypotension, hypoglycemia, or confusion in a patient with adrenal insufficiency who missed hydrocortisone doses
- Planned abrupt stop of chronic systemic hydrocortisone without taper—risk of adrenal crisis per labeling
- Rigors or worsening sepsis markers with minimal inflammatory appearance because corticosteroids mask classic signs
- Severe or persistent hyperglycemia symptoms (polyuria, dehydration, altered mental status) after high-dose IV therapy
- Hypernatremia or edema when high-dose IV continues beyond 48–72 hours per labeling warning
- Signs of systemic fungal infection, anaphylaxis to drug, or acute psychiatric disturbance
Adverse effects
| Adverse effect | Notes (labeling) | Nursing response |
|---|---|---|
| Hyperglycemia | Increased insulin requirement; glucose intolerance | Increase glucose monitoring frequency; notify prescriber for sustained elevation |
| Fluid/electrolyte | Sodium retention, potassium loss, edema; hypernatremia with prolonged high-dose IV | Trend BMP including potassium; monitor weight and edema |
| Immunosuppression / masked infection | May decrease resistance to infection; may mask fever and inflammation | Low threshold to culture and escalate in febrile immunocompromised patients |
| HPA axis suppression | With prolonged systemic therapy | Ensure taper plan; teach stress-dose rules and medical alert identification |
| GI / psychiatric | Peptic ulcer symptoms, mood changes, insomnia reported with corticosteroids | Monitor GI bleeding cues and mental status; report acute psychiatric symptoms |
| Hypersensitivity | Anaphylactoid reactions possible | Stop infusion/push and escalate per allergy protocol |
On a small screen, swipe or scroll sideways to see the full table.
Overdose, toxicity, and antidote
Acute overdose signs reflect exaggerated pharmacologic effects: hyperglycemia, edema, hypertension, hypokalemia, and mood or psychotic disturbances. Chronic excess contributes to Cushingoid features and immune suppression.
Antidote
Not specified in the reviewed prescribing information — there is no listed specific reversing agent. Treatment is supportive and symptomatic.
Management per labeling
- Supportive care tailored to presenting toxicity (glucose management, blood pressure monitoring, electrolyte correction)
- Reduce dose gradually when overdose reflects chronic excess—avoid abrupt withdrawal that triggers adrenal crisis
- Contact local poison control or medical toxicology services per facility protocol for significant overdose or unexpected severe toxicity
Look-alike / sound-alike and error prevention
- Hydrocortisone vs methylprednisolone vs dexamethasone — different potency and duration; crash-cart grab errors have caused under- or over-treatment
- Solu-Cortef vs Solu-Medrol — similar prefix; read generic name on vial and verify mg
- Oral hydrocortisone vs prednisone — not milligram-equivalent; conversion requires pharmacist verification
- Home double-dose stress plan vs scheduled MAR dose — reconcile written endocrine plan at admission
- IV push rate errors — 100 mg over 30 seconds versus 500 mg over 10 minutes; independent double-check
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Morning replacement | Many regimens give larger oral dose on waking to mimic diurnal cortisol peak |
| NPO / vomiting | Switch to IV/IM sodium succinate when oral route unreliable—do not skip stress coverage |
| Surgery / ICU transfer | Flag steroid-dependent patients on handoff; ensure stress-dose orders follow the patient |
| Glucose checks | Pair corticosteroid doses with bedside glucose monitoring—especially when diabetes is on the problem list |
| Taper discipline | Document each taper step; patients need clear instructions before discharge |
| Ask pharmacy when | Conversion between corticosteroids, compatibility questions, or unclear crisis dosing |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Primary adrenal insufficiency | Cannot increase endogenous cortisol—missed doses during sepsis, trauma, or surgery precipitate crisis; always maintain stress coverage |
| Secondary adrenal suppression | Patients tapered off long-term prednisone may still need stress dosing for 6–12 months per endocrine guidance—confirm history |
| Critical illness / sepsis | Requires increased corticosteroid dosage during unusual stress per labeling; coordinate with fluid resuscitation and vasopressors |
| Diabetes mellitus | Higher glucose variability; insulin or oral agent adjustment often needed |
| Active or latent infection | Immunosuppression may worsen outcomes; corticosteroids may mask fever |
| Pregnancy / lactation | Use only if benefit justifies risk; coordinate with obstetric and endocrine teams |
| Older adults | Higher risk of hyperglycemia, fluid retention, confusion, and delirium—monitor closely |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Blood pressure, heart rate, mental status, and perfusion during crisis and stress dosing
- Glucose at increased frequency when on high-dose or IV therapy—especially in known diabetes; use structured blood glucose monitoring per protocol
- BMP: sodium, potassium, glucose, creatinine during high-dose or prolonged therapy
- Infection indicators (temperature trend, WBC, lactate, cultures)—even when patient appears comfortable on steroids
- Signs of volume overload or hypernatremia when IV doses continue beyond 48–72 hours
Document
- Indication (replacement, stress, crisis), dose, route, exact push duration or infusion rate
- Home hydrocortisone reconciliation and any missed doses before admission
- Glucose values correlated with corticosteroid timing
- Taper plan and patient teaching on stress doses and medical alert jewelry
Patient teaching
- Never stop hydrocortisone suddenly without prescriber guidance—carry emergency steroid instructions
- When vomiting or unable to take oral tablets, seek care for IM/IV stress dosing per your action plan
- Report fever, infection symptoms, dizziness, confusion, or excessive thirst—steroids can hide infection and raise glucose
- Wear medical alert identification for adrenal insufficiency
- Do not receive live vaccines during high-dose immunosuppressive therapy without prescriber approval
- Keep a supply of oral stress-dose tablets when traveling if instructed by endocrinology
The Hold Rule
Do not give and contact the prescriber/pharmacist when:
- Known hydrocortisone hypersensitivity or active anaphylaxis to the drug
- Systemic fungal infection without coordinated antifungal and prescriber plan per labeling
- Order specifies IM route in idiopathic thrombocytopenic purpura
- Any attempt to administer intrathecally
- Live vaccine ordered during immunosuppressive corticosteroid doses—clarify timing with prescriber
Important: Do not withhold ordered replacement or stress-dose hydrocortisone in suspected adrenal crisis while waiting for clarification—escalate for missing orders instead. Hold parameters may vary by institutional protocol.
Clinical practice integration and workflow
Hydrocortisone errors cluster around two gaps: assuming oral home doses continue unnoticed after admission, and treating sepsis without stress-dose corticosteroid coverage in adrenal-insufficient patients.
1. Check-before-you-give protocol
- Right patient, drug, dose, route, time—and right indication (replacement vs stress vs crisis)
- Confirm oral capability; if NPO or vomiting, clarify IV/IM sodium succinate orders
- For Solu-Cortef: reconstitute per labeling, no dilution/mixing, verify push duration
- Scan for missed home doses on admission documentation
2. High-alert and safety badge
Crisis and stress-dose IV hydrocortisone warrants high-alert independent double-check practices—errors cause adrenal collapse or wrong corticosteroid selection3. Clinical workflow: hold and question rules
- If a steroid-dependent patient arrives hypotensive with missed doses, question absent stress-dose orders before giving only fluids or vasopressors
- If glucose rises after IV hydrocortisone, notify prescriber rather than assuming self-limiting hyperglycemia
- Never discontinue inpatient corticosteroids at discharge without explicit taper instructions
4. Critical teach-back questions
- “What will you do if you vomit and cannot keep your hydrocortisone tablets down?” (Patient should describe calling for care and using stress-dose IM/IV plan per endocrine instructions.)
- “What infection symptoms should you report even if you do not have a high fever?” (Patient should name rigors, wound redness, confusion, or feeling severely unwell while on steroids.)
5. Care coordination
Pharmacist: Corticosteroid conversion, Solu-Cortef preparation, interaction review, and glucose management recommendations
Prescriber: Notify for refractory hypotension, missed stress coverage, hyperglycemia needing insulin adjustment, suspected infection on immunosuppressive doses, or taper planning at discharge
🧠 Quick mental checklist
- Did admission reconciliation capture home hydrocortisone and stress-dose instructions?
- Is the patient NPO or vomiting—and is parenteral coverage ordered?
- Any hypotension, hypoglycemia, or confusion suggesting adrenal crisis?
- What is the glucose trend since the last corticosteroid dose?
- Are infection signs present even if fever is blunted?
Hydrocortisone NCLEX practice questions
Rehearse NCLEX-style clinical judgment practice for hydrocortisone using a tabbed Addison-crisis case (MAR, labs, vitals, nursing notes), then priority action, cue-recognition SATA, glucose trend SATA, matrix urgency sorting, IV push-rate judgment, and overdose cloze—with explicit evaluate outcomes items after stress-dose therapy.
Select a tab to view MAR, labs, vitals, and nursing note details for this case.
- Home hydrocortisone 20 mg PO qAM + 10 mg PO qPM — held on admission pending endocrine consult; no IV stress dose ordered yet
- Normal saline 100 mL/h IV continuous
- Ceftriaxone 1 g IV q24h — due 1400 for sepsis
- Insulin lispro sliding scale — no fixed dose; last correction 0900
- Acetaminophen 650 mg PO q6h PRN fever — given 0800
- Glucose 112 (admission) → 186 (0600) → 248 mg/dL (1100 BMP)
- Sodium 134 mEq/L; potassium 4.0 mEq/L
- WBC 14.2 → 18.6 K/µL; lactate 2.4 mmol/L
- Cultures pending from ED
- BP 102/64 → 94/58 → 88/52 mmHg (1100)
- HR 96 → 108 → 112/min
- Temp 38.4 °C → 38.9 °C; RR 22/min; SpO2 96% on 2 L NC
- Patient reports dizziness when sitting up
- 58-year-old with Addison disease admitted from ED with sepsis; family reports missed morning hydrocortisone for 2 days during GI illness
- 0900: alert but fatigued; skin warm; mild rigors
- 1030: increasing dizziness; asks nurse to stay at bedside when standing
- 1100: endocrine consult pending; nurse reviewing tabs before next intervention
Answer key & rationale
Frequently asked questions
What should I check before giving hydrocortisone?
Confirm indication (replacement, stress dose, or acute adrenal crisis), review blood glucose, blood pressure, infection signs, and recent corticosteroid exposure including home doses held on admission. Verify allergies, active systemic fungal infection, and whether oral route is feasible. Match MAR dose, route, and push/infusion rate to labeling—Solu-Cortef must not be diluted or mixed with other IV solutions.
When should nurses hold hydrocortisone?
Hold and contact the prescriber or pharmacist for known hypersensitivity, systemic fungal infection without concurrent antifungal therapy per labeling, IM use in idiopathic thrombocytopenic purpura, or intrathecal administration attempts. Do not withhold replacement or stress-dose therapy in adrenal crisis when ordered—instead escalate if orders are missing. Question live vaccine administration during immunosuppressive doses.
Why is missed stress dosing dangerous in Addison disease?
Patients with adrenal insufficiency cannot mount a cortisol response to physiologic stress. Labeling states dosage must be increased during unusual stress; abrupt withdrawal after prolonged therapy can precipitate adrenal crisis with hypotension, hypoglycemia, and cardiovascular collapse. Nurses should reconcile home hydrocortisone at admission, ensure stress-dose IV coverage during sepsis or surgery, and never stop chronic therapy without a taper plan.
How fast can IV hydrocortisone sodium succinate be given?
Solu-Cortef labeling directs IV push over 30 seconds for the 100 mg dose and over at least 10 minutes for 500 mg or more. Initial parenteral doses of 100 to 500 mg may be repeated every 2 to 6 hours. High-dose IV therapy is usually not continued beyond 48 to 72 hours because prolonged administration may cause hypernatremia.
Is there an antidote for hydrocortisone overdose?
No specific antidote is listed in the reviewed prescribing information. Overdose is managed with supportive and symptomatic treatment. Contact local poison control or medical toxicology services per facility protocol for significant overdose or unexpected severe hyperglycemia, hypertension, or psychiatric disturbance.
References
- U.S. National Library of Medicine. HYDROCORTISONE SODIUM SUCCINATE injection — SPL product labeling (Solu-Cortef). DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5bb0854-a477-4e59-914b-eeeaef92a596
- U.S. National Library of Medicine. HYDROCORTISONE tablet — SPL product labeling. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=451d6d04-b7d9-47d9-ba71-43cc5b9b3054
- Joint Formulary Committee. Hydrocortisone monograph. BNF (NICE).https://bnf.nice.org.uk/drugs/hydrocortisone/
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.